Kidney failures doubled in last 15 years in India: Health experts

Published On 2016-03-11 03:59 GMT   |   Update On 2024-02-20 08:50 GMT

The number of Indians suffering from kidney failures has doubled in the last 15 years with a rise of 10 percent in the number of citizens undergoing dialysis due to chronic kidney diseases (CKD), health experts have said.According to them, several Indian population-based studies in the past estimated the incidence of End-Stage Kidney Disease (ESKD) is 150-230 per million and about...

Login or Register to read the full article
The number of Indians suffering from kidney failures has doubled in the last 15 years with a rise of 10 percent in the number of citizens undergoing dialysis due to chronic kidney diseases (CKD), health experts have said.

According to them, several Indian population-based studies in the past estimated the incidence of End-Stage Kidney Disease (ESKD) is 150-230 per million and about 220,000-275,000 new patients need Renal Replacement Therapy (RRT) every year.

"It is estimated that approximately 75,000 patients are on dialysis which is growing at the rate of 10-20 percent annually. The question is whether India has the resources and skill to handle this ever-increasing population of ESKD in India," said Dr Rajesh Kumar, consultant nephrologist at Mumbai-based SRV Hospital.

Stating that the exact burden of chronic kidney diseases in India is still undefined, the approximate prevalence of CKD is 800 per million populations (pmp).

Accoring to the experts, one percent of the Gross Domestic Product (GDP) in India is spent on the health sector while the figure in China is three percent and 8.3 percent in the US.

Earlier figures have shown that 65 percent diagnosed patients do not receive dialysis and medical treatment on time.

"Looking at these facts, it is a challenge to cope up with an ever-increasing ESKD population who require Renal Replacement therapy (RRT) in the form of Hemodialysis, Continuous Ambulatory Peritoneal Dialysis or Kidney Transplantation. Hence a sincere and serious attempt is necessary to bring down the cost of dialysis treatment," Dr Kumar told IANS.

According to Dr Pradeep Gadge, a diabeteologist with Seven Hills and Breach Candy Hospitals in Mumbai, diabetes is considered as the most common causes for kidney failures and it is estimated that over one million patients worldwide are alive on dialysis.

"With this exponential increase in diabetic patients in India, the number of patients with kidney ailments is likely to rise high," he noted, adding that every year, an estimated 3.5-4 lakh new cases are likely to be diagnosed with kidney ailments.

"Diabetes and blood pressure are most common cause of kidney disease in adults but in children, Chronic glomerulonephritis and Recurrent UTI (Reflux) are the most important causes apart from congenital anomalies of urinary system," Dr Gadge said.

Throwing light on the facilities for dialysis, Dr M.M. Bahadur, nephrologist at Wockhardt Hospital, said: "Two lakh patients in a year reach the CAPD (Continuous Ambulatory Peritoneal Dialysis) stage 5 where they need dialysis of which less than 10 percent actually get treated due to non-availability of facility, cost factor and proximity."

Continuous Ambulatory Peritoneal Dialysis means diaysis throughout the day, at home or at work. During CAPD, a bag of dialysis fluid is drained into the peritoneal cavity through a Tenckhoff Catheter.

"With only 300-400 dialysis centres available in India and with 1,500 nephrologist in metro cities who treat kidney patients, more than 60 percent of the patients do not receive medical attention on time. Only four percent of the patients get donors," noted Dr Bahadur.

According to the health ministry, 2,000 new dialysis centres will be set up at district-level hospitals in the country within the next two years to tackle the problem.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News